SCHEMBL26298560

SCHEMBL26298560

Cc1[nH]c2c3ccccc3n(C)c2c1-c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ ALKBH5 Q6P6C2 1/20 0.44
▸ FTO Q9C0B1 1/20 0.44
▸ KDM4E B2RXH2 3/20 0.42
▸ MAPT P10636 1/20 0.42
▸ GPR3 P46089 1/20 0.41
▸ CDK4 P11802 3/20 0.40
▸ CCND1 P24385 3/20 0.40
▸ HSD17B10 Q99714 3/20 0.40
▸ HPGD P15428 2/20 0.40
▸ HSP90AA1 P07900 1/20 0.39
▸ IDO1 P14902 1/20 0.39
▸ MDM2 Q00987 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ CAMK2B Q13554 1/20 0.38
▸ CAMK2G Q13555 1/20 0.38
▸ CAMK2D Q13557 1/20 0.38
▸ CAMK2A Q9UQM7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8704226 0.86 ALDH1A1 (0.46) LMNAKMT2ASMN1; SMN2KDM4EMAPT
SCHEMBL26298608 0.76 ALKBH5 (0.45) LMNAKMT2AALKBH5FTOKDM4E
SCHEMBL26168250 0.75 LMNA (0.44) LMNAKMT2ASMN1; SMN2ALKBH5FTO
SCHEMBL26297617 0.72 LMNA (0.47) LMNAKMT2ASMN1; SMN2ALKBH5FTO
SCHEMBL26168119 0.72 KMT2A (0.54) LMNAKMT2ASMN1; SMN2ALKBH5FTO
SCHEMBL29634190 0.72 KMT2A (0.54) LMNAKMT2ASMN1; SMN2ALKBH5FTO
SCHEMBL17029497 0.71 CDK4 (0.55) LMNAKMT2AALKBH5FTOKDM4E
SCHEMBL9955515 0.70 KDM4E (0.51) LMNAKMT2ASMN1; SMN2ALKBH5FTO
SCHEMBL9959682 0.70 KDM4E (0.51) LMNAKMT2ASMN1; SMN2ALKBH5FTO
SCHEMBL20568392 0.69 GPR35 (0.43) LMNAKMT2ASMN1; SMN2KDM4ECDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230276696-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORP (US) 2023-08-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230276696-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, PORCN LMNA 2148/4885KMT2A 4003/4885SMN1; SMN2 4189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback